Regeneron Pharmaceuticals, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Old Saw Mill River Road, Tarrytown, NY

Insiders trading volume in the past year

Regeneron Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
George Yancopoulos Bd. Co-Chair, President & CSO, Director $1.13B Jun 10, 2024
Leonard S. Schleifer Bd. Co-Chair, President & CEO, Director $687M Jun 11, 2024
Vagelos P Roy Director $444M Apr 3, 2023
Neil Stahl EVP Research and Development $43.3M Dec 16, 2024
Andrew Murphy EVP Research $30.6M Oct 29, 2025
Joseph Larosa EVP General Counsel and Secret $27.6M Nov 20, 2025
Daniel P. Van Plew EVP & General Mgr, Industrial $26.2M Dec 16, 2024
Robert E. Landry EVP Finance CFO $22.9M Feb 2, 2024
George L. Sing Director $21.2M Dec 31, 2024
Christopher R. Fenimore SVP Finance & CFO $14.4M Dec 16, 2024
Arthur F. Ryan Director $12.6M Jan 2, 2025
Marion McCourt EVP Commercial $10.5M Dec 16, 2024
Michael S. Brown Director $9M Jan 2, 2025
Joseph L. Goldstein Director $4.64M Jan 2, 2025
Jason Pitofsky VP Controller $2.88M -$281K -8.9% Nov 7, 2025
Christine A. Poon Director $2.63M -$4.25M -61.8% Oct 29, 2025
Marc Tessier-Lavigne Director $2.32M Jan 3, 2023
Bonnie L. Bassler Director $1.16M -$570K -32.9% Nov 20, 2025
N. Anthony Coles Director $1.1M Jan 2, 2025
Huda Y. Zoghbi Director $1.1M Jan 2, 2025
Craig B. Thompson Director $439K Jan 2, 2025
Kathryn Guarini Director $317K Jan 2, 2025
David P. Schenkein Director $317K Jan 2, 2025

Recent Insider Transactions by Companies or Individuals for Regeneron Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.